| Pharmaceutical active ingredients: |
| Dihydroergotamine Mesylate |
| Available forms, composition and doses of Seglor: |
| Capsules; Oral; Dihydroergotamine Mesylate 5 mgSolution; Oral; Dihydroergotamine Mesylate 2 mg / ml |
| Seglor medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA01 - Dihydroergotamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schwarz PharmaPharmafairSanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Migranil Injections | Dihydroergotamine Mesylate | Inga Laboratories |
| Morena | Dihydroergotamine Mesylate | 3M |
| Orstanorm | Dihydroergotamine Mesylate | Novartis |
| Pervone | Dihydroergotamine Mesylate | Sanofi-Aventis |
| Poligot | Dihydroergotamine Mesylate | Polipharm, Thailand |
| Seglor Lyoc | Dihydroergotamine Mesylate | Schwarz Pharma |
| Tamik | Dihydroergotamine Mesylate | IPRAD Laboratoires; C & L Pharmaceutical; Marcofina Laboratoire |
| Tenuatina | Dihydroergotamine Mesylate | Rottapharm |
| Tonopres | Dihydroergotamine Mesylate | Boehringer Ingelheim |
| Verladyn | Dihydroergotamine Mesylate | Verla-Pharm Arzneimittelfabrik |